Humboldt Chemical’s Xerxes plant is both a workplace and the physical center of a widening inquiry: evidence gathered about its solvent production links years of employee illness to the company’s industrial practices, while the plant’s records and surroundings draw investigators into immediate danger. The novel moves between the site’s history and a present-day return to its production floor, making the plant a place where slow, difficult-to-prove harm becomes an urgent human crisis.

Industrial Setting and Production

Humboldt Chemical began making Xerxine at the plant in the 1950s. The chemical was a chlorinated hydrocarbon solvent, used for cleaning oil from sheet metal, paint, and other materials. During manufacture, workers could breathe chlorinated vapors. The account of the plant’s early operation does not describe deliberate efforts to injure employees; rather, it stresses that the company initially exercised inadequate control over how much vapor entered the air, at a time when the associated health risks were not widely understood.

Concern about environmental pollution and occupational health grew during the 1960s and 1970s. Researchers studying industrial pollution found that chemicals such as Xerxine could be toxic even at low concentrations. Humboldt Chemical subsequently installed air scrubbers and sealed pipes more effectively, reducing concentrations at the plant to federal standards. In the late 1970s, the U.S. Environmental Protection Agency set a Xerxine standard of fifty parts per million. These later controls describe a change in industrial practice, but they do not settle what earlier exposure had done to employees who had worked at the plant for years.

Workers and the Medical Record

The plant’s history becomes legible through the cases of Joey Pankowski and Steve Ferraro, long-term employees who left work after becoming seriously ill. Ferraro had worked for Humboldt Chemical since 1959 and Pankowski since 1961. Their illnesses included liver cancer and aplastic anemia. In 1983, they sought workers’ compensation, arguing that their illnesses were related to their jobs; the claim was not a wrongful-dismissal suit. The two men had both died by the time V. I. Warshawski learned about the case, and their lawyer, Frederick Manheim, had not pursued an appeal after consulting an appellate lawyer.

Medical records later provide a wider view than the original lawsuit had established. Dr. Chigwell’s notebooks contain blood histories for Steve Ferraro from 1957 to 1982 and for Louisa Djiak from 1963 to 1982, as well as records for approximately five hundred other employees at Humboldt Chemical’s Xerxes plant covering 1955 to 1982. A specialist’s review found changing blood measurements consistent with developing kidney, liver, and bone-marrow dysfunction. In Louisa Djiak’s case, the blood work indicated noticeable kidney damage by 1967 and severe damage by 1969. She experienced diffuse symptoms, including itching, fatigue, and headaches, around 1979, but did not then recognize them as a reason to seek medical care. Her illness was diagnosed as chronic renal failure in 1984 and had since progressed to an acute stage.

The records make the plant’s history more than a question of isolated diagnoses. They provide a long series of measurements that can be compared with the workers’ illnesses and with the known toxic properties of Xerxine. The specialist’s account describes the recorded changes as consistent with Xerxine exposure; it does not erase the evidentiary problems that had defeated the earlier compensation case.

Claims, Insurance, and Disputed Responsibility

When Joey Pankowski and Steve Ferraro brought their claim, Frederick Manheim believed Humboldt Chemical would refuse to resolve it without a lawsuit. The company argued that the men’s illnesses could have resulted from other causes: both smoked, Pankowski drank heavily, and both had lived their lives in South Chicago, whose air was already polluted. It also argued that the men had worked at the plant before the dangers of Xerxine were known and that the company had operated according to the medical knowledge of the time. The case went to trial and the workers lost. An appellate lawyer advised Manheim that there was no viable basis for an appeal.

That result explains how the claim was defeated, not why the later investigation treats it as unimportant. The records reviewed after the case connect blood changes to a period extending across decades, while the courtroom dispute had to address alternative exposures and the standards of knowledge and practice at the time. Manheim’s detailed recollection of the case conveys how thoroughly its competing explanations had occupied him, even after the litigation was over.

A separate trail begins with a 1963 letter discovered among Nancy Cleghorn’s files. It states that Jurshak & Parma had become fiduciaries for Humboldt Chemical’s Xerxes plant and encloses an actuarial study comparing the plant’s losses with those of similar local companies, requesting comparable rate treatment. The document appears ordinary on its face and does not concern the recycling proposal or another environmental issue Nancy had been investigating. Its age and unexplained presence make it a puzzle rather than proof of wrongdoing. V. I. Warshawski turns to Ron Kappelman for help understanding its possible importance, while recognizing that the document’s connection to the plant may be significant.

The Plant in the Present-Day Investigation

The plant’s name repeatedly redirects V. I. Warshawski’s attention. After she learns of the failed workers’ compensation case, a warning about possible sabotage remains unresolved: the available account did not show sabotage, but Humboldt Chemical could have kept such information quiet. Later, as V. I. Warshawski reviews the people and evidence connected to the inquiry, she concludes that Gustav Humboldt would have known about what the company was concealing concerning Joey Pankowski and Steve Ferraro. The 1963 insurance paper and the workers’ cases therefore converge on the plant without yet yielding a complete explanation of their connection.

The site also becomes a place of immediate danger. A caller tells Caroline Djiak that Louisa Djiak has been taken to the plant and is sedated, and threatens that she could be left in the lagoons behind it if police accompany V. I. Warshawski. V. I. Warshawski drives south at night with Clio Chigwell. They approach by a rough track on private industrial property, near a large cement barge, and use a dinghy as they make their way to the plant. The journey makes the industrial landscape part of the investigation’s practical obstacles, rather than merely its background.

Inside, the two women pass through an open door beside a closed steel curtain and enter the manufacturing area. Pipes release steam and cauldrons bubble beneath green safety lights; large no-smoking signs bear graffiti. There they find Louisa Djiak on a stretcher, with Dr. Chigwell and Art Jurshak standing on either side. The discovery brings the plant’s historical and present-tense strands into the same room: the site associated with long-term employee illness is also where Louisa’s immediate peril is confronted. The scene ends with Dr. Chigwell recognizing Clio, leaving the confrontation and its outcome unresolved in this passage.

Narrative Significance

The plant gathers several forms of evidence that have different limits. The workers’ compensation case shows how alternative explanations and the standards of the period could defeat a claim; the notebooks preserve repeated medical measurements across a large workforce; and the insurance letter offers a suspiciously misplaced lead without explaining itself. Their convergence turns the plant into a contested archive as well as a working industrial site.

Its significance also lies in the contrast between long duration and immediate threat. The possible health effects emerge through histories accumulated over years, while the night journey to the manufacturing floor compresses the investigation into a single dangerous visit. The plant’s pipes, air controls, production equipment, records, and adjacent lagoons belong to one material setting, but they do not provide one simple answer. Instead, each forces the inquiry to distinguish what the evidence supports from what remains to be proved.